OTUD6B and esophageal squamous cell carcinoma: The ATRA‐mediated enhancement of tumor response to anti‐PD‐1 treatment relies on the existence of OTUD6B mRNA, since in OTUD6B‐knockdown ESCC tumors, ATRA could not improve the effects of anti‐PD‐1 immunotherapy (Figure 7J,K).